FDA Inspection 1287248 — ZenRise Clinical Research Pvt., Ltd

ZenRise Clinical Research Pvt., Ltd — FEI 3014350907

The FDA completed an inspection of ZenRise Clinical Research Pvt., Ltd on Aug 22, 2025 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 22, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hyderabad (India)

Additional Details

Bioanalytical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.